Francisco Antônio Helfenstein Fonseca

Statistics

Publications

Citations

26.8K

H-Index

Active since

1997

Affiliations

Universidade Federal de São Paulo(Current)

Universidade de São Paulo

Brigham and Women's Hospital

Harvard University

Hospital Israelita Albert Einstein

Francisco Antônio Helfenstein Fonseca is an author at Universidade Federal de São Paulo specializing in medicine, cardiovascular disease, and pharmacotherapy.

ORCID

Publications per year

1997–2022

Publications

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Paul M. Ridker, Tom Thurén, Jean MacFadyen et al. · New England Journal of Medicine · 2017 · 9.1K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Paul M. Ridker, Francisco Antônio Helfenstein Fonseca, Jacques Genest et al. · New England Journal of Medicine · 2008 · 6.6K citations · Full text

Medicine, Cardiology, Pharmacotherapy +10

Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein

Paul M. Ridker, Francisco Antônio Helfenstein Fonseca, Jacques Genest et al. · Obstetrical & Gynecological Survey · 2009 · 3.7K citations

Medicine, Cardiology, Pharmacotherapy +10

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

Paul M. Ridker, Jean MacFadyen, Tom Thurén et al. · The Lancet · 2017 · 1.3K citations · Full text

Medicine, Oncology, Pharmacology +13

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

Paul M. Ridker, Francisco Antônio Helfenstein Fonseca, Jacques Genest et al. · The Lancet · 2009 · 1K citations

Medicine, Pharmacology, Pharmacotherapy +17

1–5 of 78